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genome-wide data sets 5-7 . Here, we combine long-and short-read whole-genome next-20 generation sequencing data with recent assembly approaches into the first de novo assembly 21 of the genome of an Egyptian individual. The resulting genome assembly demonstrates well-22 balanced quality metrics and comes with high-quality variant phasing into maternal and 23 paternal haplotypes, which are linked to various gene expression changes in blood. To 24 construct an Egyptian genome reference, we further assayed genome-wide genetic variation 25 occurring in the Egyptian population within a representative cohort of more than 100 26 Egyptian individuals. We show that differences in allele frequencies and linkage 27 disequilibrium between Egyptians and Europeans may compromise the transferability of 28
European ancestry-based genetic disease risk and polygenic scores, substantiating the need for 29 multi-ethnic genetic studies and corresponding genome references. The Egyptian genome 30 reference represents a comprehensive population data set based on a high-quality personal 31 genome. It is a proof of concept to be considered by the many national and international 32 genome initiatives underway. More importantly, we anticipate that the Egyptian genome 33 reference will be a valuable resource for precision medicine targeting the Egyptian population 34 and beyond. With the advent of personal genomics, population-based genetics as part of an individual's 39 genome is indispensable for precision medicine. Currently, genomics-based precision 40 medicine compares the patients' genetic make-up to a reference genome 9 , a genome model 41 inferred from individuals of mostly European descent, to detect risk mutations that are related 42 to disease. However, genetic and epidemiologic studies have long recognized the importance 43 of ancestral origin in conferring genetic risk for disease. Risk alleles and structural variants 44 (SVs) 10 can be missing from the reference genome or can have different population 45 frequencies, such that alternative pathways become disease related in patients of different 46 ancestral origin, which motivates the establishment of national or international multi-ethnic 47 genome projects 6, 7, 11 . At present, there are several population-based sequencing efforts that 48 aim to map specific variants in the 100,000 genome projects in Asia 12 or England 13 . 49
Furthermore, large-scale sequencing efforts currently explore population, society and history-50 specific genomic variations in individuals in Northern and Central Europe 14,15 , North 51 66 In this study, we generated a phased de novo assembly of an Egyptian individual and 67 identified single nucleotide variants (SNVs) and SVs from an additional 109 Egyptian 68 individuals obtained from short-read sequencing. Those were integrated to generate an 69 Egyptian genome reference. We anticipate that an Egyptian population genome reference will 70 strengthen precision medicine efforts that eventually benefit nearly 100 million Egyptians, 71 e.g., by providing allele frequencies (AFs) and linkage disequilibrium (LD) between variants, 72 information that is necessary for both rare and common disease studies. Likewise, our 73 genome will be of universal value for research purposes, since it contains both European and 74
African variant features. Most genome-wide association studies (GWAS) are performed in 75 Europeans 29 , but genetic disease risk may differ, especially for individuals of African 76 ancestry 30 . Consequently, an Egyptian genome reference will be well suited to support recent 77 efforts to include Africans in such genetic studies, for example, by serving as a benchmark 78 data set for SNP array construction and variant imputation or for fine-mapping of disease loci. 79
80
Our Egyptian genome is based on a high-quality human de novo assembly for one Egyptian 81 individual (see workflow in Suppl. Fig. 1 ). This assembly was generated from PacBio, 10x 82
Genomics and Illumina paired-end sequencing data at overall 270x genome coverage (Suppl. 83 Table 1 ). For this personal genome, we constructed two draft assemblies, one based on long-84 read assembly by an established assembler, FALCON 31 , and another based on the assembly by 85 a novel assembler, WTDBG2 32 , which has a much shorter run time with comparable accuracy 86 (cf. Suppl. Fig. 1 ). Both assemblies were polished using short reads and various polishing 87 tools. For the FALCON-based assembly, scaffolding was performed, whereas we found that 88 the WTDBG2-based assembly was of comparable accuracy without scaffolding (cf. dot plots in 89 Suppl. Figs. 3-4). The WTDBG2-based assembly was selected as the base because it performs 90 comparable or better according to various quality control (QC) measures (Suppl. The meta-assembly was complemented with high-quality phasing information (Suppl. Table  101 5). EGYPT SNVs and small insertions and deletions (indels) called using short-read 102 sequencing data were phased using high-coverage 10x linked-read sequencing data. This 103 resulted in 98.99% of variants being phased. Furthermore, nearly all (99.41%) of the genes 104 with lengths less than 100 kb and more than one heterozygous SNP were phased into a single 105 phase block. 106 107 Based on the personal Egyptian genome, we constructed an Egyptian population genome by 108 considering genome-wide SNV AFs in 109 additional Egyptians (Suppl. Table 6 ). This 109 approach enabled the characterization of the major allele (i.e., the allele with highest AF) in 110 the given Egyptian cohort. To accomplish this, we called variants using short-read data of 13 111
Egyptians sequenced at high coverage and 97 Egyptians sequenced at low coverage. Although 112 sequence coverage affects variant-based statistics (Suppl. Fig. 8 ), due to combined 113 genotyping, most variants could also be called reliably in low coverage samples (Suppl. Fig.  114 9). Altogether, we called a total of 19,758,992 SNVs and small indels (Suppl. Fig. 10 ) in all 115 110 Egyptian individuals (Fig. 1 ). The number of called variants per individual varied 116 between 2,901,883 to 3,934,367 and was correlated with sequencing depth (see Suppl. Figs. 117 8-9). This relationship was particularly pronounced for low coverage samples. The majority 118 of variants were intergenic (53.5%) or intronic (37.2%) (Suppl. Fig. 11 ). Only approximately 119 0.7% of the variants were located within coding exons, of which 54.4% were non-120 synonymous and thus cause a change in protein sequence and possibly structure (Suppl. Fig.  121 12). 122 123 Using short-read sequencing data of 110 Egyptians, we called 121,141 SVs, most of which 124 were deletions but also included inversions, duplications, insertions and translocations of 125 various orders of magnitude ( Fig. 1 , Suppl. Fig. 13-14 ). Similar to SNVs, the number of SV 126 calls also varied between individuals (Suppl. Fig. 15 ) and is slightly affected by coverage 127 (Suppl. Fig. 16 ). After merging overlapping SV calls, we obtained an average of 2,773 SVs 128 per Egyptian individual (Suppl. The mixed European and African ancestry of Egyptians is further supported by mitochondrial 142 haplogroup assessment from the literature 27 and our own mtDNA sequencing data (overall 143 n=327). We found that Egyptians have haplogroups most frequently found in Europeans (e.g., 144 H, V, T, J, etc.; more than 60%), and many Egyptians also have African (e.g., L with 24.8%) 145 or Asian/East Asian haplogroups (e.g., M with 6.7%). This indicates that Egyptian genomes 146 contain genetic components from various major human populations (Suppl. Fig. 33 ), as has 147 been shown recently for a few Egyptian individuals in a study that performed genome-wide 148 admixture analysis of populations from the Arabian Peninsula using SNP arrays 25 . 149
150
In total, we identified 6,599,037 common Egyptian SNVs (minor allele frequency (MAF) > 151 5%, genotypes in a minimum of 100 individuals), of which 1,198 are population-specific; i.e., 152 they are either rare (MAF < 1%) or not detected in any other population in the 1000 Genomes 153 populations 36 . Four SNVs likely have a molecular impact (Suppl . Table 10) , indicated by a 156 CADD 37 deleteriousness score greater than 20. SNP rs143563851 (CADD 24.2) has recently 157 been identified in 1% of individuals of a cohort of 211 Palestinians in a study that performed 158 targeted sequencing of blood group antigen synthase GBGT1 38 . SNP rs143614333 (missense 159 variant in gene CR2, CADD 23.6) is in ClinVar 39 , with three submitters reporting that the 160 variant is of uncertain clinical significance. Additionally, we obtained 49 variants with no 161 dbSNP 40 rsID (Suppl . Table 11 ). These numbers of population-specific SNPs, of which some 162 likely have an immediate impact on clinical characteristics and diagnostics, indicate 163 insufficient coverage of the genetic diversity of the world's population for precision medicine 164 and thus the need for local genome references. To detect a putative genetic contribution of 165
Egyptian population-specific SNPs towards molecular pathways, phenotypes or disease, we 166 performed gene set enrichment analysis for all 461 protein-coding genes that were annotated 167 to population-specific SNPs by Ensembl VEP 41 . Enrichr, a gene list enrichment tool 168 incorporating 153 gene sets and pathway databases 42 , reports that genes from obesity-related 169 traits of the GWAS catalog 2019 collection are over-represented (adj. p-value: 1.02E-6; 49 of 170 804 genes), which might hint at population-specific metabolism regulation that is linked to 171 body weight. 172
173
Variants that are not protein coding may have a regulatory effect that affects gene and 174 eventually protein expression. Using blood expression data obtained from RNA sequencing 175 for the EGYPT assembly individual in conjunction with 10x sequencing-based phased variant 176 data, we identified genes whose expression differs between maternal and paternal haplotypes 177 (see Suppl. Fig. 34 . Table 13 ). Egyptian AFs of tag SNPs are 199 comparable to European AFs, with a tendency to be lower ( Fig. 3a ). There are variants 200 common in Europeans (AF>5%) but rare in Egyptians (AF<5%) (Suppl. Fig. 37 ). A total of 201 261 tag SNPs are not present in the Egyptian cohort (~7%), clearly indicating a need to 202 perform GWAS in non-European populations to further elucidate disease risk conferred by 203 these loci. We investigated differences in LD structure using an approach that is used for fine-204 mapping of GWAS data, which identifies proxy variants (illustrated in Fig. 3c ). Proxy 205 variants are variants correlated with the tag GWAS SNP, i.e., in high LD (here, R 2 >0.8). The 206 post-GWAS challenge is the identification of a causal variant from a set of variants in LD (tag 207 SNP and proxy variants). We found that the number of proxy variants was much lower in the 208 Egyptian cohort (Fig. 3b ), likely due to shorter haplotype blocks known from African 209 populations. This indicates that LD differences between Egyptians and Europeans may 210 compromise GWAS transferability and European ancestry-based polygenic scores. However, 211
Egyptian proxy variants are usually included in the larger set of European proxy variants ( Fig.  212   3d ). An example is variant rs2075650 (a locus sometimes attributed to gene TOMM40), 213 which has been linked to Alzheimer's disease in seven GWASs (cf. Suppl. Fig. 38 ). This tag 214 SNP has seven proxy variants in Europeans but only two proxy variants in Egyptians. One 215 European proxy, rs72352238, has also been reported as a GWAS tag SNP, but it is not a 216 proxy of rs2075650 in Egyptians and may thus fail replication and transfer of GWAS results 217 from the European to the Egyptian population. In conclusion, we constructed the first Egyptian -and North African -genome reference, 234 which is an essential step towards a comprehensive, genome-wide knowledge base of the 235 world's genetic variations. The wealth of information it provides can be immediately utilized 236
to study in-depth personal genomics and common Egyptian genetics and its impact on 237 molecular phenotypes and disease. This reference will pave the way towards a better 238 understanding of the Egyptian, African and global genomic landscape for precision medicine. For 350 bp library construction, the genomic DNA was sheared, and fragments with sizes of 258 approximately 350 bp were purified from agarose gels. The fragments were ligated to 259 adaptors and amplified using PCR. The generated libraries were then sequenced on the 260
Illumina HiSeq X Ten using PE150 and generated 312.8 GB of data. 261
For the assembly individual, sequencing data from five libraries was generated at overall 90x 262 genome coverage. For nine additional individuals, one library each was generated, amounting 263 to an overall 305x coverage of sequencing data. For the 100 individuals of Pagani et al. 27 , 264 three were sequenced at high coverage (30x) and 97 at low coverage (8x). The average 265 coverage over SNV positions for all 110 samples is provided in Supplementary Table 6 . 266
267

RNA sequencing data generation 268
For RNA sequencing, ribosomal RNA was removed from total RNA, double-stranded cDNA 269 was synthesized, and then adaptors were ligated. The second strand of cDNA was then 270 degraded to generate a directional library. The generated libraries with insert sizes of 250-300 271 bp were selected and amplified and then sequenced on the Illumina HiSeq using PE150. www.10xgenomics.com). The generated fragments were sheared, and then adaptors were 278 ligated. The generated libraries were sequenced on the Illumina HiSeq X Ten using PE150 279 and generated 272.7 GB of data. Sequencing data from four 10x libraries was generated at 280 overall 80x genome coverage. 281 282
Construction of draft de novo assemblies and meta-assembly 283
We used WTDBG2 32 for human de novo assembly followed by its accompanying polishing 284 tool WTPOA-CNS with PacBio reads and in a subsequent polishing run with Illumina short 285 reads. This assembly was further polished using PILON 49 with short-read data (cf. Suppl. 286
Methods: WTDBG2-based assembly). 287
An alternative assembly was generated by using FALCON 50 , QUIVER 51 , SSPACE-288 LONGREAD 52 , PBJELLY 53 , FRAGSCAFF 54 and PILON 49 (cf. Suppl. Methods: 289
FALCON-based assembly). 290
Proceeding from the WTDBG2-based assembly, we constructed a meta-assembly. Regions 291 larger than 800 kb that were not covered by this base assembly and were not located within 292 centromere regions were extracted from the alternative FALCON-based assembly (Suppl. 293 Table 3 ). See Suppl. Fig. 1 for an overview of our assembly strategy, including meta-294 assembly construction (cf. Suppl. Methods: Meta-assembly construction). 295
Assembly quality and characteristics were assessed with QUAST-LG 55 (cf. Suppl. Methods: 296
Assembly comparison and QC). The extraction of coordinates for meta-assembly construction 297 was performed using QUAST-LG output. 
SNVs and small indels 312
Calling of SNVs and small indels was performed with GATK 3.8 57 using the parameters of 313 the best practice workflow. Reads in each read group were trimmed using Trimmomatic 58 314 and subsequently mapped against reference genome hg38 using BWA-MEM 59 version 0.7.17. 315
Then, the alignments for all read groups were merged sample-wise and marked for duplicates. 316
After the base recalibration, we performed variant calling using HaplotypeCaller to 317 obtain GVCF files. These files were input into GenotypeGVCFs to perform joint genotyping. 318
Finally, the variants in the outputted VCF file were recalibrated, and only those variants that 319 were flagged as "PASS" were kept for further analyses. We used FastQC 60 , Picard 320 
Population-specific variants 347
Our set of common Egyptian SNVs comprises variants with genotypes in a minimum of 100 348 individuals whose alternative allele has a frequency of more than 5%. Those common 349
Egyptian SNVs that are otherwise rare, i.e., have an AF of less than 1% in the 1000 Genomes, 
